Skip to main content
Caplight Logo









Polar NanoPharma

Polar NanoPharma

Private
SpainHealthcare & Life Scienceshttps://polarnanopharma.com/

Last Round

Grant

May 27, 2026

Total Funding Raised

$21,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Polar NanoPharma is a biotechnology company that develops advanced nanoparticle-based drug delivery systems for oncology applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

targeted drug deliverynanocarriersnanomedicinedrug encapsulationoncology drug developmentbiotechnologycontrolled releasebioavailabilitypolymer-based deliveryprecision medicinedrug delivery platformbiotech spin-outdrug formulationsmart drug deliverynanotech pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polar NanoPharma Comparables

Compare Polar NanoPharma with similar companies based on industry and business-model similarity.

Polar NanoPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Libera Bio
87%
QurCan Therapeutics
83%
InnoUp Farma
77%

Polar NanoPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 27, 2026
Pre SeedJan 1, 2026
AcceleratorFeb 20, 2025

Key People

Founding team and executive leadership

Iván Ramos Tomillero

Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 192% MoM, reaching 587.

  • May 27, 2026

    $21K grant received from EmprendeXXI Awards and Spanish Chamber of Commerce.

Polar NanoPharma Filings

Explore SEC and related filing metadata, where available.

Polar NanoPharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Polar NanoPharma's valuation, stock price, and market status.

Is Polar NanoPharma a public or private company?

Polar NanoPharma is a private company.

What is the current stock price of Polar NanoPharma?

Polar NanoPharma is a private company with no public stock price. No recent secondary market data is available.

How much is Polar NanoPharma worth (valuation)?

Valuation information for Polar NanoPharma is not publicly available.

Can I buy Polar NanoPharma stock?

Polar NanoPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Polar NanoPharma's last funding round?

Polar NanoPharma's most recent funding round was Grant on May 27, 2026.

Who are the main investors in Polar NanoPharma?

Investor information for Polar NanoPharma is not publicly disclosed.

Will Polar NanoPharma IPO soon?

No public IPO plans have been announced for Polar NanoPharma.

How can I track Polar NanoPharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Polar NanoPharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSpain
Employee Range2
Year Founded2024
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?